On November 19, 2019, the U.S. Food and Drug Administration approved cenobamate (XCOPRI®) for the treatment of focal epilepsy in adults. This medication will be available in the pharmacy by the spring or summer of 2020.
I've been a professional copywriter for over 35 years. I also had epilepsy for decades.
My mission is advocacy; to increase education, awareness and funding for epilepsy research.
Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.